Our Transformative Approach
Revolutionizing Drug Development Through LADR4
Starting with drug substances already approved for human use, LADR4 applies a modifying agent from a curated library to create an improved, patentable drug. LADR4 is a chemical modification approach (not a formulation) and does not trigger a 505(b)(1) path.
Key Points of Our Approach
What Makes LADR4 Different
1
Develop ~4× faster than traditional models.
2
Approx. ~2% of traditional cost basis.
3
Higher probability of success vs. conventional pathways.
4
Chemical modification → patentable NCEs; avoids 505(b)(1) 10–12 year, $1–3B path.